Wealth Management industry news covering the financial markets, trends and wealth professionals.
Stay up to date with Wealth Management news and trends through our free Morning Memo e-newsletter. Join today.
When selecting hedge funds for your clients, don’t look for home runs, said Mark Willoughby, principle and wealth manager of Modera Wealth Management, during an fi360 webinar this week. Hedge funds and other alternative strategies can provide a...
Kristi Kuechler, the former president of the Institute for Private Investors and a high-profile figure in the ultra-high-net-worth world, has been named a partner and managing director at Lattice Strategies, a San Francisco-based investment...
Five years ago, John Vance was looking for ways to boost revenues at Vance Wealth Group, the Valencia, Calif.-based practice that he’d started two years before. Doing so, he realized, meant introducing more efficient systems and delegating more to...
As Americans continue to struggle with finances, a consortium of financial planners will sharply broaden an annual outreach next month to consumers looking for free professional advice. The second annual Financial Planning Days, as the program is...
The Internet is freewheeling “ether,” where, it seems, anyone can say anything about anyone or anything. Wealth managers are becoming increasingly concerned about how to effectively manage their valuable, but vulnerable, reputations. They are even...
Yesterday, I came across a data-free screed on Registered Rep. lambasting the financial advisory community in general and the way it is compensated specifically. The piece was written by Andrew J. Haigney, Managing Director of El Cap Investment...
UBS top brass sent out a blitzkrieg of reassurances to its prized financial advisors Monday to keep them in their seats and get them to reach out to potentially nervous clients. The effort follows the double whammy of bad news about the bank out...
Health stocks have faced strong headwinds. The sluggish economy has caused patients to postpone elective surgery, while pharmaceutical companies have been hurt by healthcare reform and expirations of patents on blockbuster drugs. Should you avoid...